glp-1 obesity drug news today oct 2025 Compound versions of drugs for weight loss halted by FDA GLP-1 Agonists Market Report 2025-2033,

Oxyntomodulin, another endogenous ligand of the GLP-1R and the glucagon receptor and allosteric ligands of the GLP-1R have been reported to exhibit some degrees of G-protein bias at the GLP-1R 31,32

GLP-1Rs are also present on Schwann cells and sensory, motor, and enteric neurons, implicating them in peripheral neuropathy and metabolic disease modulation [73]

Scenario D: Unintended Pregnancy During GLP-1RA Therapy (Safety Management) Background: unintended conception may occur during GLP-1RA-assisted weight-loss treatment, particularly if contraception is inconsistent during dose escalation or periods of improved cycle regularity

GLP-1 Coverage and Cost Transparency for Members and Plans The GLP-1 boom illustrates how difficult it can be to predict and prepare for a sudden surge in utilization and costly claims, or the next shortage

Eye Twitching and Abnormal Blinking Eye twitching, also known as eyelid twitching or myokymia, is a repetitive, involuntary spasm of the eyelid muscles

was supported by the National Institutes of Health COURAGE grant (U24 DK132733)